Global Colorectal Cancer Molecular Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Colorectal Cancer Molecular Diagnostics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Colorectal Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent and Daangene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Colorectal Cancer Molecular Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Colorectal Cancer Molecular Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Colorectal Cancer Molecular Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Colorectal Cancer Molecular Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Colorectal Cancer Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Colorectal Cancer Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.


Colorectal Cancer Molecular Diagnostics Segment by Company

Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx

Colorectal Cancer Molecular Diagnostics Segment by Type

Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others

Colorectal Cancer Molecular Diagnostics Segment by Application

Hospital
Third-Party Testing Agency
Others

Colorectal Cancer Molecular Diagnostics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colorectal Cancer Molecular Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colorectal Cancer Molecular Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colorectal Cancer Molecular Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Colorectal Cancer Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Colorectal Cancer Molecular Diagnostics industry.
Chapter 3: Detailed analysis of Colorectal Cancer Molecular Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colorectal Cancer Molecular Diagnosticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Third-Party Testing Agency
1.3.4 Others
1.4 Global Market Growth Prospects
1.5 Global Colorectal Cancer Molecular Diagnostics Growth Trends by Region
1.5.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Colorectal Cancer Molecular Diagnostics Market Size by Region (2020-2025)
1.5.3 Colorectal Cancer Molecular Diagnostics Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Colorectal Cancer Molecular Diagnostics Market Dynamics
2.1 Colorectal Cancer Molecular Diagnostics Industry Trends
2.2 Colorectal Cancer Molecular Diagnostics Industry Drivers
2.3 Colorectal Cancer Molecular Diagnostics Industry Opportunities and Challenges
2.4 Colorectal Cancer Molecular Diagnostics Industry Restraints
3 Competitive Landscape by Company
3.1 Global Colorectal Cancer Molecular Diagnostics Revenue by Company (2020-2025)
3.2 Global Colorectal Cancer Molecular Diagnostics Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Colorectal Cancer Molecular Diagnostics Key Company Head office and Area Served
3.4 Global Colorectal Cancer Molecular Diagnostics Company, Product Type & Application
3.5 Global Colorectal Cancer Molecular Diagnostics Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Colorectal Cancer Molecular Diagnostics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Colorectal Cancer Molecular Diagnostics Players Market Share by Revenue in 2024
3.6.3 2024 Colorectal Cancer Molecular Diagnostics Tier 1, Tier 2, and Tier 3
4 Colorectal Cancer Molecular Diagnostics Market by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2020-2031)
4.3 Global Colorectal Cancer Molecular Diagnostics Market Size Share by Type (2020-2031)
5 Colorectal Cancer Molecular Diagnostics Market by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2031)
5.3 Global Colorectal Cancer Molecular Diagnostics Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Comapny Information
6.1.2 Roche Diagnostics Business Overview
6.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product Portfolio
6.1.5 Roche Diagnostics Recent Developments
6.2 Abbott
6.2.1 Abbott Comapny Information
6.2.2 Abbott Business Overview
6.2.3 Abbott Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Abbott Colorectal Cancer Molecular Diagnostics Product Portfolio
6.2.5 Abbott Recent Developments
6.3 Thermo Fisher
6.3.1 Thermo Fisher Comapny Information
6.3.2 Thermo Fisher Business Overview
6.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product Portfolio
6.3.5 Thermo Fisher Recent Developments
6.4 Qiagen
6.4.1 Qiagen Comapny Information
6.4.2 Qiagen Business Overview
6.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Qiagen Colorectal Cancer Molecular Diagnostics Product Portfolio
6.4.5 Qiagen Recent Developments
6.5 Illumina
6.5.1 Illumina Comapny Information
6.5.2 Illumina Business Overview
6.5.3 Illumina Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Illumina Colorectal Cancer Molecular Diagnostics Product Portfolio
6.5.5 Illumina Recent Developments
6.6 Biomerieux
6.6.1 Biomerieux Comapny Information
6.6.2 Biomerieux Business Overview
6.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Biomerieux Colorectal Cancer Molecular Diagnostics Product Portfolio
6.6.5 Biomerieux Recent Developments
6.7 Bio-Rad
6.7.1 Bio-Rad Comapny Information
6.7.2 Bio-Rad Business Overview
6.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Bio-Rad Colorectal Cancer Molecular Diagnostics Product Portfolio
6.7.5 Bio-Rad Recent Developments
6.8 Agilent
6.8.1 Agilent Comapny Information
6.8.2 Agilent Business Overview
6.8.3 Agilent Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Agilent Colorectal Cancer Molecular Diagnostics Product Portfolio
6.8.5 Agilent Recent Developments
6.9 Daangene
6.9.1 Daangene Comapny Information
6.9.2 Daangene Business Overview
6.9.3 Daangene Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Daangene Colorectal Cancer Molecular Diagnostics Product Portfolio
6.9.5 Daangene Recent Developments
6.10 Amoydx
6.10.1 Amoydx Comapny Information
6.10.2 Amoydx Business Overview
6.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 Amoydx Colorectal Cancer Molecular Diagnostics Product Portfolio
6.10.5 Amoydx Recent Developments
7 North America
7.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)
7.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type
7.2.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2020-2025)
7.2.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2026-2031)
7.2.3 North America Colorectal Cancer Molecular Diagnostics Market Share by Type (2020-2031)
7.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Application
7.3.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2025)
7.3.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2026-2031)
7.3.3 North America Colorectal Cancer Molecular Diagnostics Market Share by Application (2020-2031)
7.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country
7.4.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)
7.4.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)
7.4.4 North America Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)
8.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type
8.2.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2020-2025)
8.2.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2026-2031)
8.2.3 Europe Colorectal Cancer Molecular Diagnostics Market Share by Type (2020-2031)
8.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application
8.3.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2025)
8.3.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2026-2031)
8.3.3 Europe Colorectal Cancer Molecular Diagnostics Market Share by Application (2020-2031)
8.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country
8.4.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)
8.4.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)
8.4.4 Europe Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)
9.2 China Colorectal Cancer Molecular Diagnostics Market Size by Type
9.2.1 China Colorectal Cancer Molecular Diagnostics Market Size by Type (2020-2025)
9.2.2 China Colorectal Cancer Molecular Diagnostics Market Size by Type (2026-2031)
9.2.3 China Colorectal Cancer Molecular Diagnostics Market Share by Type (2020-2031)
9.3 China Colorectal Cancer Molecular Diagnostics Market Size by Application
9.3.1 China Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2025)
9.3.2 China Colorectal Cancer Molecular Diagnostics Market Size by Application (2026-2031)
9.3.3 China Colorectal Cancer Molecular Diagnostics Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)
10.2 Asia Colorectal Cancer Molecular Diagnostics Market Size by Type
10.2.1 Asia Colorectal Cancer Molecular Diagnostics Market Size by Type (2020-2025)
10.2.2 Asia Colorectal Cancer Molecular Diagnostics Market Size by Type (2026-2031)
10.2.3 Asia Colorectal Cancer Molecular Diagnostics Market Share by Type (2020-2031)
10.3 Asia Colorectal Cancer Molecular Diagnostics Market Size by Application
10.3.1 Asia Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2025)
10.3.2 Asia Colorectal Cancer Molecular Diagnostics Market Size by Application (2026-2031)
10.3.3 Asia Colorectal Cancer Molecular Diagnostics Market Share by Application (2020-2031)
10.4 Asia Colorectal Cancer Molecular Diagnostics Market Size by Country
10.4.1 Asia Colorectal Cancer Molecular Diagnostics Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)
10.4.3 Asia Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)
10.4.4 Asia Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)
11.2 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type
11.2.1 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application
11.3.1 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country
11.4.1 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings